Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Aberrant folding of pathogenic Parkin mutants: aggregation versus degradation.
J Biol Chem. 2008 May 16;283(20):13771-9. doi: 10.1074/jbc.M707494200. Epub 2008 Mar 24.
J Biol Chem. 2008.
PMID: 18362144
Free article.
Inactivation of parkin by oxidative stress and C-terminal truncations: a protective role of molecular chaperones.
Winklhofer KF, Henn IH, Kay-Jackson PC, Heller U, Tatzelt J.
Winklhofer KF, et al. Among authors: henn ih.
J Biol Chem. 2003 Nov 21;278(47):47199-208. doi: 10.1074/jbc.M306769200. Epub 2003 Sep 12.
J Biol Chem. 2003.
PMID: 12972428
Free article.
Item in Clipboard
Pathogenic mutations inactivate parkin by distinct mechanisms.
Henn IH, Gostner JM, Lackner P, Tatzelt J, Winklhofer KF.
Henn IH, et al.
J Neurochem. 2005 Jan;92(1):114-22. doi: 10.1111/j.1471-4159.2004.02854.x.
J Neurochem. 2005.
PMID: 15606901
Free article.
Item in Clipboard
Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling.
Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE, Wegener E, Nakaso K, Culmsee C, Berninger B, Krappmann D, Tatzelt J, Winklhofer KF.
Henn IH, et al.
J Neurosci. 2007 Feb 21;27(8):1868-78. doi: 10.1523/JNEUROSCI.5537-06.2007.
J Neurosci. 2007.
PMID: 17314283
Free PMC article.
Item in Clipboard
Cite
Cite